Estates and Trusts - Interpretation of Wills - Evidence of Intent (Granny's Law)
HB 375, titled the “Granny’s Law,” would change Maryland’s Estates and Trusts law to give a personal representative new authority to ask the orphans’ court to interpret a decedent’s will based on extrinsic evidence of the decedent’s intent. The bill is aimed at situations where a will leaves a legacy to a health provider or charitable organization connected to health equity or other documented disparities, but the will does not expressly say the gift must be used for that purpose. In those cases, the personal representative could present evidence of the decedent’s lifetime actions and interests to show that the legacy should be used to address health equity issues.
The bill also creates a mechanism for post-probate oversight of certain legacies. If the will contains specified broad administrative language, the court must defer to the personal representative’s judgment, and the representative may require the legatee to show how the legacy was used during a period beginning six months after probate and ending three years later. If the legatee cannot demonstrate compliance with the court’s interpretation, the representative may seek an order requiring the beneficiary to return the gift or a judgment for its value. The bill applies retroactively to wills probated on or after October 1, 2021, and takes effect October 1, 2026.
HB 375 would also add a new policy statement to the Health-General Article declaring that Maryland opposes and seeks to reduce racial disparities in health outcomes and encourages gifts and bequests that support that policy. Although the bill is framed as an estates-and-trusts measure, it would effectively connect probate administration to state health equity policy and could affect charitable beneficiaries, health providers, estate administrators, and heirs or legatees receiving restricted gifts.
The available context shows no recorded votes or committee testimony, so there is no documented floor or committee sentiment beyond the bill’s introduction and hearing. Based on the text, the bill appears intended to strengthen enforcement of a decedent’s charitable intent and to direct legacy funds toward health-disparity reduction, suggesting a policy goal of accountability and equity. At the same time, the bill’s retroactive application and its authority for personal representatives to challenge how beneficiaries use inherited funds could raise concerns about uncertainty in probate administration and potential disputes over donor intent.
Notable points of contention are likely to include whether courts should rely on extrinsic evidence to reinterpret wills, how much discretion personal representatives should have over charitable legacies, and whether beneficiaries should be required to account for how they spend inherited funds. The bill’s focus on health equity and racial disparities may also draw debate over whether it appropriately advances public policy through probate law or instead creates new litigation risk and uncertainty for estates and charitable organizations.
HB 375 would amend Maryland’s Estates and Trusts law, specifically Section 7-402, to authorize personal representatives in certain cases to petition the orphans’ court to interpret a will according to the decedent’s intent using extrinsic evidence. It would also allow a personal representative to require certain legatees to demonstrate how a legacy was used and, if necessary, to seek return of the legacy or a money judgment. In addition, the bill adds a new Health-General policy statement supporting efforts to reduce racial health disparities and encouraging gifts and bequests aligned with that policy. The bill applies retroactively to wills probated on or after October 1, 2021, and would take effect October 1, 2026.
The bill’s stated purpose suggests generally supportive sentiment around honoring donor intent and directing charitable gifts toward health equity goals. Because there are no recorded votes or committee transcripts in the provided context, there is no direct evidence of opposition or support from legislators or witnesses. On its face, the measure appears to be framed as a reform to help personal representatives and courts enforce a decedent’s wishes, especially in the context of charitable gifts tied to health disparities.
The main areas of potential contention are the bill’s reliance on extrinsic evidence to interpret wills, the expanded authority given to personal representatives to police how legatees use inherited funds, and the retroactive application to wills already probated since 2021. Critics may question whether the bill could create uncertainty for estates and beneficiaries or invite litigation over donor intent, while supporters are likely to emphasize accountability, protection of the decedent’s wishes, and the policy goal of addressing health inequities. The bill may also prompt debate over whether probate law is the right vehicle for advancing public health equity policy.